Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-Hu CD69 PerCP

CD69 (C-type lectin domain family 2 C, CLEC2C, also known as AIM) is one of the earliest inducible cell surface molecules acquired during leukocyte activation. This glycoprotein serves as a lectin-type receptor in lymphocytes, NK cells and platelets; it is involved in lymphocyte proliferation. CD69 expression is counteracted on T cells in the AIDS stage of HIV infection, and may be also predictive for clinical response to chemoimmunotherapy.

Product Specifications

Certification

RUO

Reactivity

Human

Immunogen

Anti-µ -stimulated human B lymphocytes

Target Antigen

CD69

Clone

FN50

Applications

FC (QC tested)

Format

PerCP

Buffer

Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

References & Citations

*Hrdinka M, Dráber P, Stepánek O, Ormsby T, Otáhal P, Angelisová P, Brdicka T, Paces J, Horejsí V, Drbal K: PRR7 is a transmembrane adaptor protein expressed in activated T cells involved in regulation of T cell receptor signaling and apoptosis. J Biol Chem. 2011 Jun 3;286 (22) :19617-29., URL: http://www.ncbi.nlm.nih.gov/pubmed/21460222 , *Ohradanova-Repic A, Machacek C, Charvet C, Lager F, Le Roux D, Platzer R, Leksa V, Mitulovic G, Burkard TR, Zlabinger GJ, Fischer MB, Feuillet V, Renault G, Blüml S, Benko M, Suchanek M, Huppa JB, Matsuyama T, Cavaco-Paulo A, Bismuth G, Stockinger H: Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances. Front Immunol. 2018 Apr 27;9:852., URL: https://www.ncbi.nlm.nih.gov/pubmed/29780382 , *Leukocyte Typing IV., Knapp W. et al. (Eds.), Oxford University Press (1989) ; p. 293., URL: , *Drbal K, Moertelmaier M, Holzhauser C, Muhammad A, Fuertbauer E, Howorka S, Hinterberger M, Stockinger H, Schütz GJ: Single-molecule microscopy reveals heterogeneous dynamics of lipid raft components upon TCR engagement. Int Immunol. 2007 May;19 (5) :675-84., URL: https://www.ncbi.nlm.nih.gov/pubmed/17446208?itool, *Tomescu C, Chehimi J, Maino VC, Montaner LJ: NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells. J Immunol. 2007 Aug 15;179 (4) :2097-104., URL: https://www.ncbi.nlm.nih.gov/pubmed/17675468, *Quardokus EM, Saunders DC, McDonough E, Hickey JW, Werlein C, Surrette C, Rajbhandari P, Martinez Casals A, Tian H, Lowery L, Neumann EK, Björklund F, Neelakantan TV, Croteau J, Wiblin AE, Fisher J, Livengood AJ, Dowell KG, Silverstein JC, Spraggins JM, Pryhuber GS, Deutsch G, Ginty F, Nolan GP, Melov S, Jonigk D, Caldwell MA, Vlachos IS, Mueller W, Gehlenborg N, Stockwell BR, Lundberg E, Snyder MP, Germain RN, Camarillo JM, Kelleher NL, Börner K, Radtke AJ: Organ mapping antibody panels: a community resource for standardized multiplexed tissue imaging. Nat Methods 2023 Aug;20 (8) :1174-1178. doi: 10.1038/s41592-023-01846-7., URL: https://pubmed.ncbi.nlm.nih.gov/37468619/

Other References

*Konjević G, Jović V, Vuletić A, Radulović S, Jelić S, Spuzić I: CD69 on CD56+ NK cells and response to chemoimmunotherapy in metastatic melanoma. Eur J Clin Invest. 2007 Nov;37 (11) :887-96., URL: https://www.ncbi.nlm.nih.gov/pubmed/17973783?ordin, *Pitsios C, Dimitrakopoulou A, Tsalimalma K, Kordossis T, Choremi-Papadopoulou H: Expression of CD69 on T-cell subsets in HIV-1 disease. Scand J Clin Lab Invest. 2008;68 (3) :233-41., URL: https://www.ncbi.nlm.nih.gov/pubmed/17917998?ordin, *Nielsen SD, Afzelius P, Ersbøll AK, Nielsen JO, Hansen JE: Expression of the activation antigen CD69 predicts functionality of in vitro expanded peripheral blood mononuclear cells (PBMC) from healthy donors and HIV-infected patients. Clin Exp Immunol. 1998 Oct;114 (1) :66-72., URL: https://www.ncbi.nlm.nih.gov/pubmed/9764605?ordina, *López-Cabrera M, Santis AG, Fernández-Ruiz E, Blacher R, Esch F, Sánchez-Mateos P, Sánchez-Madrid F: Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med. 1993 Aug 1;178 (2) :537-47., URL: https://www.ncbi.nlm.nih.gov/pubmed/8340758?ordina

Storage Conditions

Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.

Specificity

The mouse monoclonal antibody FN50 recognizes an extracellular epitope of CD69, an lymphocyte early activation marker.

Applications Notes

6

Isotype

Mouse IgG1

More Discoveries

Explore Other Products

Browse additional items from our catalog

Pou3f1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
37260114 3x 1.0 µg

Pou3f1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

Sign In for Pricing
View Details
APC/Cyanine7 anti-human CD49d
GT08072 25 Tests

APC/Cyanine7 anti-human CD49d

Sign In for Pricing
View Details
LETM1 Polyclonal Antibody
bs-15591R 100 µL

LETM1 Polyclonal Antibody

Sign In for Pricing
View Details
L-Carnitine Test Kit
EOK0448 48 Tests

L-Carnitine Test Kit

Sign In for Pricing
View Details
NMDA epsilon 1/2 Polyclonal Antibody
MBS8524130-01 0.1 mg

NMDA epsilon 1/2 Polyclonal Antibody

Sign In for Pricing
View Details
NMDA epsilon 1/2 Polyclonal Antibody
MBS8524130-02 0.1 mL (AF635)

NMDA epsilon 1/2 Polyclonal Antibody

Sign In for Pricing
View Details